Insider Transactions Reported by 24 Insiders of Lyell Immunopharma, Inc.

Symbol
LYEL on Nasdaq
Location
South San Francisco, CA

Insiders trading volume in the past year

Lyell Immunopharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
ROBERT NELSEN Director, 10%+ Owner $83M 14 Jun 2024
GSK plc 10%+ Owner $69M 21 Jun 2021
Hans Edgar Bishop Director $10.7M 14 Jun 2024
ARCH Venture Partners IX, LLC 10%+ Owner $8.54M 25 Jul 2025
ARCH Venture Fund XIII, L.P. 10%+ Owner $4.4M 25 Jul 2025
Richard Klausner Director $1.79M +$94.9K +5.6% 15 May 2025
Lynn Seely President and CEO, Director $1.08M +$14.7K +1.38% 10 Nov 2025
Charles W. Newton Chief Financial Officer $290K +$93.5K +47.6% 20 Aug 2025
Stephen J. Hill Chief Operating Officer $254K -$14K -5.24% 10 Nov 2025
Gary K. Lee Chief Scientific Officer $248K -$20.3K -7.57% 10 Nov 2025
CATHY FRIEDMAN Director $158K 15 May 2025
Veronica Sanchez Bulis VP, Corporate Controller $148K -$3.85K -2.53% 10 Nov 2025
Matthew Lang Chief Business Officer $114K 10 Feb 2025
Sumant Ramachandra Director $94K +$115K 15 May 2025
OTIS W. BRAWLEY Director $16.8K +$20K 15 May 2025
Tina M. Albertson Chief Medical Officer $9.23K 24 Feb 2023
David Shook Chief Medical Officer $8.76K 09 Jun 2025
ELIZABETH G. NABEL Director 15 May 2025
Rahsaan Thompson Chief Legal Officer 24 Feb 2023
Heather D. Turner Chief General Counsel 16 Mar 2022
Mark Bachleda Director 09 Jun 2025
Mark A. Meltz General Counsel 09 Jun 2025
Elizabeth Homans Chief Executive Officer, Director 16 Mar 2022
WILLIAM JL RIEFLIN Director 15 May 2025

Recent Insider Transactions by Companies or Individuals for Lyell Immunopharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.